contents area
주간건강과질병
detail content area
[QuickStats] 만성폐쇄성폐질환 유병률 추이, 2007-2017
- 작성일2019-02-07
- 최종수정일2021-04-15
- 담당부서만성질환관리과
- 연락처043-719-7383
만성폐쇄성폐질환 유병률 추이, 2007-2017
Trends in prevalence of Chronic Obstructive Pulmonary Disease(COPD) among Korean adults aged ≥ 40, 2007-2017
[정의] 폐쇄성폐질환 유병률 : 폐기능검사 결과 기류제한(FEV1/FVC < 0.7)이 있는 분율, 만40세 이상
만40세 이상의 만성폐쇄성폐질환 유병률(연령표준화)은 2007년 15.2%에서 2017년 11.6%로 3.6%p 감소하였으며, 남자의 경우가 여자보다 감소경향이 더 뚜렷하였음. 2017년 기준 남자의 만성폐쇄성폐질환 유병률은 18.2%로 여자(5.9%)에 비해 약 3배 높았음(그림 A).
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) among Korea adults aged 40 years and over decreased to 11.6% in 2017, a reduction of 3.6 percentage points (%p) from 15.2% in 2007. The reduction width among men was slightly bigger than that among women. The 2017 data indicated that the prevalence of COPD among men (18.2%) was three folds higher than that among women (5.9%) (Figure A).
Source: Korea Health Statistics 2017, Korea National Health and Nutrition Examination Survey, http://knhanes.kdca.go.kr/
Reported by: Division of Chronic Disease Control, Korea Centers for Disease Control and Prevention
Trends in prevalence of Chronic Obstructive Pulmonary Disease(COPD) among Korean adults aged ≥ 40, 2007-2017
[정의] 폐쇄성폐질환 유병률 : 폐기능검사 결과 기류제한(FEV1/FVC < 0.7)이 있는 분율, 만40세 이상
만40세 이상의 만성폐쇄성폐질환 유병률(연령표준화)은 2007년 15.2%에서 2017년 11.6%로 3.6%p 감소하였으며, 남자의 경우가 여자보다 감소경향이 더 뚜렷하였음. 2017년 기준 남자의 만성폐쇄성폐질환 유병률은 18.2%로 여자(5.9%)에 비해 약 3배 높았음(그림 A).
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) among Korea adults aged 40 years and over decreased to 11.6% in 2017, a reduction of 3.6 percentage points (%p) from 15.2% in 2007. The reduction width among men was slightly bigger than that among women. The 2017 data indicated that the prevalence of COPD among men (18.2%) was three folds higher than that among women (5.9%) (Figure A).
Source: Korea Health Statistics 2017, Korea National Health and Nutrition Examination Survey, http://knhanes.kdca.go.kr/
Reported by: Division of Chronic Disease Control, Korea Centers for Disease Control and Prevention
본 공공저작물은 공공누리 "출처표시+상업적이용금지+변경금지" 조건에 따라 이용할 수 있습니다.